Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNexus Gene Lab Corp.

3.10
-0.1200-3.73%
Post-market: 3.170.0700+2.26%19:31 EDT
Volume:46.83K
Turnover:146.54K
Market Cap:5.57M
PE:-5.85
High:3.21
Open:3.12
Low:3.00
Close:3.22
Loading ...
Oct 31, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 05, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 06, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 09, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]